UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☐
Filed by a Party other than the Registrant ☒
Check the appropriate box:
☐
Preliminary Proxy Statement
☐
Confidential, for Use of... (continue reading...)
As filed with the Securities and Exchange Commission on May 18, 2022
Registration No. 333-173752
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Post-Effective Amendment No. 1
to
FORM S-3
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
NAVIDEA BIOPHARMACEUTICALS, INC.
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
Delaware
2835
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 2)*
KALEYRA, INC.
(Name of Issuer)
Common Stock, par value of $0.0001 per share
(Title of Class of Securities)
483379103
(CUSIP Number)
December 31, 2021
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is... (continue reading...)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of 1934
May 2022
Commission File Number: 001-37925
GDS Holdings Limited
(Registrant’s name)
F4/F5, Building C, Sunland International
No. 999 Zhouhai Road
Pudong, Shanghai 200137
People’s Republic of China
(Address of principal... (continue reading...)
More SEC Filings
View Older Stories-
Form 20-F NATIONAL STEEL CO For: Dec 31
-
Form 424B4 OKYO Pharma Ltd
-
Form 6-K UTSTARCOM HOLDINGS CORP. For: May 18
-
Form 8-K Keros Therapeutics, Inc. For: May 18
-
Form 13F-HR/A MUFG Securities EMEA For: Mar 31
-
Form 6-K CHINA SOUTHERN AIRLINES For: May 18
-
Form C-AR Luxury Camping Inc. For: Dec 31
-
Form C Vegpalapp LLC
-
Form SD CHINA MOBILE LTD /ADR/
-
Form 10-Q/A CAMBER ENERGY, INC. For: Jun 30
-
Form C Rainshine Global Inc.
-
Form D/A Marshall Wace Managed
-
Form 425 Spirit Airlines, Inc. Filed by: Frontier Group Holdings, Inc.
-
Form 6-K IMMUTEP Ltd For: May 18
-
Form 424B5 PPG INDUSTRIES INC
-
Form DEFA14A MCDONALDS CORP
-
Form 8-K Sports Ventures Acquisit For: May 17
-
Form 6-K HDFC BANK LTD For: May 17
-
Form 8-K Baker Hughes Co For: May 17
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form QUALIF Fundrise Development
-
Form 8-K Franklin BSP Capital For: May 18
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K MILLICOM INTERNATIONAL For: May 18
-
Form 6-K BIONOMICS LIMITED/FI For: May 18
-
Form EFFECT EVERSOURCE ENERGY
-
Form SC TO-I/A PLAYSTUDIOS, Inc. Filed by: PLAYSTUDIOS, Inc.
-
Form AW ImmunityBio, Inc.
-
Form 424B3 Virgin Orbit Holdings,
-
Form SC 13D KIDPIK CORP. Filed by: DABAH EZRA
-
Form 424B3 PLAYSTUDIOS, Inc.
-
Form 424B3 CITIGROUP INC
-
Form 8-K Live Oak Bancshares, For: May 17
-
Form EFFECT Cortexyme, Inc.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form D AG DLI V (Unlevered),
-
Form 424B2 JPMORGAN CHASE & CO
-
Form SC 13D Hailiang Education Group Filed by: Feng Hailiang
-
Form FWP UNITEDHEALTH GROUP INC Filed by: UNITEDHEALTH GROUP INC
-
Form EFFECT Kiniksa Pharmaceuticals,
-
Form SC 13D/A KE Holdings Inc. Filed by: Baihui Partners L.P.
-
Form SC 13G Celcuity Inc. Filed by: Soleus Capital Master Fund, L.P.
-
Form 8-K Aspira Women's Health For: May 18
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K PLAYSTUDIOS, Inc. For: May 13
-
Form 424B2 CITIGROUP INC
-
Form D Granite Equity Associate
-
Form D Aruene Corp